Bond, David J <br/><br/>
Weight gain, obesity, and metabolic indices following a first manic episode: prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM).  [electronic resource] 

 -  Journal of affective disorders  Jul 2010 
 - 108-17 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-2517 
<br/><br/><label>Standard No.: </label>10.1016/j.jad.2009.10.023  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antimanic Agents--adverse effects<br/>Antipsychotic Agents--adverse effects<br/>Benzodiazepines--adverse effects<br/>Bipolar Disorder--blood<br/>Blood Glucose--metabolism<br/>Body Mass Index<br/>Cholesterol--blood<br/>Dibenzothiazepines--adverse effects<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Insulin--blood<br/>Lithium Carbonate--adverse effects<br/>Male<br/>Obesity--blood<br/>Olanzapine<br/>Overweight--blood<br/>Prospective Studies<br/>Quetiapine Fumarate<br/>Risperidone--adverse effects<br/>Triglycerides--blood<br/>Valproic Acid--adverse effects<br/>Weight Gain--drug effects<br/>Young Adult